Enimmune corporation (6564.TWO)
TWD 19.15
(1.06%)
TWD 19.15
(1.06%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 173.46 Million TWD | 58.15% |
| 2022 | 109.68 Million TWD | 173.95% |
| 2021 | 40.03 Million TWD | -0.78% |
| 2020 | 40.35 Million TWD | 606.2% |
| 2019 | 5.71 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 241.02 Million TWD | 155.87% |
| 2024 Q1 | -431.36 Million TWD | -348.68% |
| 2023 Q3 | 173.46 Million TWD | 32.8% |
| 2023 FY | 173.46 Million TWD | 58.15% |
| 2023 Q2 | 130.62 Million TWD | 0.0% |
| 2023 Q1 | 130.62 Million TWD | 19.09% |
| 2023 Q4 | 173.46 Million TWD | 0.0% |
| 2022 FY | 109.68 Million TWD | 173.95% |
| 2022 Q4 | 109.68 Million TWD | 0.0% |
| 2022 Q3 | 109.68 Million TWD | 0.0% |
| 2021 FY | 40.03 Million TWD | -0.78% |
| 2020 FY | 40.35 Million TWD | 606.2% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 70.271% |
| Level Biotechnology Inc. | 273.2 Million TWD | 36.507% |
| Sagittarius Life Science Corp | 137.82 Million TWD | -25.858% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 12.158% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 86.936% |
| GlycoNex Incorporation | 276.39 Million TWD | 37.242% |
| VBI | 21.25 Million TWD | -716.258% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 44.705% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 66.295% |
| Visgeneer Inc. | 185.6 Million TWD | 6.542% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 86.891% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 76.335% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -44.721% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 92.277% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -2521.079% |
| TaiRx, Inc. | 60.62 Million TWD | -186.125% |
| CHO Pharma, Inc. | 110.83 Million TWD | -56.51% |
| EirGenix Inc. | 1.14 Billion TWD | 84.852% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -54.904% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 66.149% |
| Lin BioScience, Inc. | 167.73 Million TWD | -3.418% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -85.098% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | -175.19% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | -39.072% |
| Lukas Biomedical Inc. | 161.05 Million TWD | -7.702% |
| RBC Bioscience Corporation | 513.08 Million TWD | 66.192% |
| BiOptic Inc. | 170.56 Million TWD | -1.7% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -311.459% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -645.917% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -546.936% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 82.202% |
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -2380.169% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -717.219% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 52.906% |
| Neith Corporation | 17.43 Million TWD | -895.027% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -2075.903% |
| NaviFUS Corp. | 53.4 Million TWD | -224.831% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 63.973% |
| Sinew Pharma Inc. | 39.71 Million TWD | -336.78% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -198.873% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 52.408% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 23.817% |
| AP Biosciences Inc | 106.65 Million TWD | -62.647% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 95.086% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -465.376% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 11.494% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 88.76% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 79.98% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -1770.019% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -210.793% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 25.539% |
| TCI GENE Inc. | 155.54 Million TWD | -11.517% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -580.034% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -275.664% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 47.191% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -167.331% |
| PharmaEngine, Inc. | 91 Million TWD | -90.606% |
| Savior Lifetec Corporation | 457.95 Million TWD | 62.122% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -56.357% |
| OBI Pharma, Inc. | 650.44 Million TWD | 73.332% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 55.615% |
| Acepodia, Inc. | 384.47 Million TWD | 54.883% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -102.755% |